This IQVIA whitepaper shows how AI is transforming life sciences commercialization, based on a 2025 survey of 107 senior leaders. Over 80% have moved beyond pilots, with 36% “AI Advanced” and nearly half dedicating 20%+ of budgets to AI. ROI is strong—58% report 2X returns within a year. Adoption is highest in IT/data operations, while sales, marketing, and compliance lag. Barriers include fragmented data, legacy systems, privacy rules, and talent shortages. Success requires enterprise AI strategies, strong governance, vendor partnerships, and scaling use cases like automation, patient support, and supply optimization.

Join for free to read